[REFERENCE TRANSLATION]
Please note that this translation is to be used solely as reference and the financial statements in this material are unaudited. In case of any discrepancy between this translation and the Japanese original, the latter shall prevail.
This translation is subject to change without notice. Linical Co., Ltd. shall accept no responsibility or liability for damage or loss caused by any error, inaccuracy, misunderstanding, or changes with regard to this translation.
Consolidated Financial Results | |
for the Six Months Ended September 30, 2021 | |
(Japanese GAAP) | |
November 12, 2021 | |
Company name | ：Linical Co., Ltd. |
Stock Listing | ：Tokyo Stock Exchange |
Code No. | ：2183 |
URL | ：https://www.linical.co.jp/ |
Representative | ：Kazuhiro Hatano, President & Chief Executive Officer |
Contact | ：Akihiro Takahashi, Executive Vice President, Chief Financial Officer |
Scheduled date of filing of quarterly report | : November 15, 2021 | ||||||||||||||||||||
Scheduled date of start of dividend payment | : － | ||||||||||||||||||||
Preparation of supplementary materials for the quarterly | : Yes | ||||||||||||||||||||
financial statements | (for institutional investors and analysts) | ||||||||||||||||||||
Holding of presentation for the quarterly financial results | : Yes | ||||||||||||||||||||
（All amounts are rounded down to the nearest million yen） | |||||||||||||||||||||
1．Consolidated Financial Results for the Six Months Ended September 30, 2021 | |||||||||||||||||||||
（April 1, 2021 to September 30, 2021） | |||||||||||||||||||||
(1)Consolidated Financial Results (cumulative) | （% figures show year-on-year change） | ||||||||||||||||||||
Net sales | Operating income | Ordinary income | Profit attributable to | ||||||||||||||||||
owners of parent | |||||||||||||||||||||
Six Months Ended | (¥ million) | change(％) | (¥ million) | change(％) | (¥ million) | change(％) | (¥ million) | change(％) | |||||||||||||
September 30, 2021 | 5,522 | 10.9 | 507 | 173.0 | 496 | 259.3 | 252 | － | |||||||||||||
September 30, 2020 | 4,981 | △7.6 | 185 | △67.4 | 138 | △71.5 | △13 | － | |||||||||||||
（Note） Comprehensive income | Six Months Ended September 30, 2021: | ¥273 million ( - %) | |||||||||||||||||||
Six Months Ended September 30, 2020: | ¥△8 million ( - %) | ||||||||||||||||||||
Net income per share | Diluted net income | ||||||||||||||||||||
per share | |||||||||||||||||||||
Six Months Ended | (¥) | (¥) | |||||||||||||||||||
September 30, 2021 | 11.18 | － | |||||||||||||||||||
September 30, 2020 | △0.61 | － | |||||||||||||||||||
(2)Consolidated Financial Position | |||||||||||||||||||||
Total assets | Net assets | Shareholders' | Net asset per | ||||||||||||||||||
equity ratio | share | ||||||||||||||||||||
(¥ million) | (¥ million) | ||||||||||||||||||||
(％) | (¥) | ||||||||||||||||||||
As of September 30, 2021 | 14,387 | 5,657 | 39.3 | 250.49 | |||||||||||||||||
As of March 31, 2021 | 15,280 | 5,712 | 37.4 | 252.92 | |||||||||||||||||
（Reference）Shareholder's equity: As of September 30, 2021: | ¥ 5,657million |
As of March 31, 2021: | ¥ 5,712million |
2．Dividends
Annual dividends per share (¥) | |||||||
1st Quarter End | 2nd Quarter End | 3rd Quarter End | Fiscal | Total | |||
Year End | |||||||
Year Ended March 31, 2021 | － | 0.00 | － | 14.00 | 14.00 | ||
Year Ending March 31, 2022 | － | 0.00 | |||||
Year Ending March 31, | － | 14.00 | 14.00 | ||||
2022(Forecast) | |||||||
(Note）Change in the dividend forecast from the most recent announcement: No
3．Forecast of Consolidated Financial Result for the Year Ending March 31, 2022
(April 1, 2021 to March 31, 2022)
（% figures show year-on-year change）
Net sales | Operating income | |||
(¥ million) | ％ | (¥ million) | ％ | |
Full year | 10,700 | 4.1 | 683 | 50.6 |
The forecast of Ordinary income and Profit attributable to owners of parent are undetermined since there are many uncertain factors such as exchange rate fluctuations.
(Note）Change in forecasts of consolidated financial results from the most recent announcement: No
- Notes
(1)Changes in significant subsidiaries during the period(changes in specified subsidiaries that caused changes in scope of consolidation)
New: | - | (Company | Name) | - |
Exclusion: | - | (Company | Name) | - |
(2)Adoption of accounting methods specific to the preparation of quarterly consolidated financial statements
(3)Changes in accounting policies, accounting estimates and restatements
1)Changes in accounting policies resulting from the revision of the accounting standards and other regulations
2)Changes in accounting policies other than 1) 3)Changes in accounting estimates 4)Restatements
(4)Number of issued shares (Common share)
(a)Number of issued shares at the end of the period (including treasury shares)
：No
：No
：Yes
：No
：No
：No
As of | September 30, 2021 |
As of | March 31, 2021 |
(b) Number of treasury shares at the end of the period
As of | September 30, 2021 |
As of | March 31, 2021 |
- Average number of shares during the period Six Months Ended September 30, 2021 Six Months Ended September 30, 2020
：24,740,000 shares
：24,740,000 shares
：2,153,564 shares
：2,153,564 shares
：22,586,436 shares
：22,586,526 shares
- This release is outside the scope of the external auditor's quarterly review procedure.
- Explanation on appropriate use of forecast and other special items
This material contains business forecast and other forward-looking statements which are based on available information and certain assumptions that are considered reasonable at the time of preparation. Various factors may cause actual results to be materially different from those expressed in these forward- looking statements.
*How to obtain supplementary results briefing material on quarterly financial results
The Company plans to hold a quarterly financial results presentation meeting on December 15, 2021. The Company also plans to post to its website the materials that are used at the meeting immediately after the event.
Consolidated Balance Sheets
(Thousands of yen) | |||
As of March 31, 2021 | As of September 30, 2021 | ||
Assets | |||
Current assets | |||
Cash and deposits | 5,084,201 | 5,062,133 | |
Accounts receivable - trade | 2,982,090 | － | |
Accounts receivable - trade and contrac | － | 2,724,783 | |
Prepaid expenses | 153,407 | 153,950 | |
Advances paid | 1,183,907 | 937,598 | |
Other | 355,957 | 206,868 | |
Allowance for doubtful accounts | △36,850 | △45,875 | |
Total current assets | 9,722,712 | 9,039,458 | |
Non-current assets | |||
Property, plant and equipment | 701,164 | 650,617 | |
Intangible assets | |||
Goodwill | 3,463,418 | 3,289,382 | |
Other | 188,469 | 166,442 | |
Total intangible assets | 3,651,888 | 3,455,825 | |
Investments and other assets | |||
Investment securities | 294,423 | 327,638 | |
Long-term prepaid expenses | 4,368 | 6,387 | |
Guarantee deposits | 449,803 | 444,914 | |
Deferred tax assets | 456,286 | 462,887 | |
Total investments and other assets | 1,204,882 | 1,241,827 | |
Total non-current assets | 5,557,935 | 5,348,269 | |
Total assets | 15,280,647 | 14,387,727 |
Consolidated Balance Sheets
(Thousands of yen) | ||||
As of March 31, 2021 | As of September 30, 2021 | |||
Liabilities | ||||
Current liabilities | ||||
Short-term borrowings | 610,799 | 510,000 | ||
Current portion of long-term borrowings | 539,976 | 539,976 | ||
Accounts payable - other | 665,588 | 555,551 | ||
Accrued expenses | 455,003 | 334,478 | ||
Income taxes payable | 203,409 | 139,588 | ||
Accrued consumption taxes | 38,793 | 49,910 | ||
Advances received | 1,909,343 | 1,829,403 | ||
Deposits received | 635,639 | 595,912 | ||
Provision for bonuses | 177,114 | 174,234 | ||
Other | 98,155 | 155,288 | ||
Total current liabilities | 5,333,824 | 4,884,344 | ||
Non-current liabilities | ||||
Long-term borrowings | 3,073,542 | 2,713,554 | ||
Lease obligations | 468,192 | 432,081 | ||
Retirement benefit liability | 645,066 | 662,467 | ||
Other | 47,400 | 37,515 | ||
Total non-current liabilities | 4,234,202 | 3,845,617 | ||
Total liabilities | 9,568,027 | 8,729,961 | ||
Net assets | ||||
Shareholders' equity | ||||
Share capital | 214,043 | 214,043 | ||
Retained earnings | 6,142,987 | 6,067,256 | ||
Treasury shares | △657,461 | △657,461 | ||
Total shareholders' equity | 5,699,568 | 5,623,838 | ||
Accumulated other comprehensive income | ||||
Valuation difference on | available-for- | 11,084 | 27,113 | |
sale securities | ||||
Foreign currency translation adjustment | △1,451 | 2,304 | ||
Remeasurements of defined benefit plans | 3,418 | 4,509 | ||
Total accumulated other | comprehensive | 13,052 | 33,927 | |
income | ||||
Total net assets | 5,712,620 | 5,657,765 | ||
Total liabilities and net assets | 15,280,647 | 14,387,727 |
This is an excerpt of the original content. To continue reading it, access the original document here.